EUVIMEDSkopri EUVIMED
Open access

Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways

Lujuan He iD, Xuenan Wang, Shilin Luo iD, Nan Jiang, Yu Yan, Min Xie, Yueyue Chen, Chun Yang iD, Wei Yao iD, Kenji Hashimoto iD, Ji-Chun Zhang iD

Science Advances · 2025

DOI: 10.1126/sciadv.adv5986 ↗

At a glance

Journal article in Science Advances, 2025. Written by Lujuan He and 10 co-authors. Institution: Department of Physiology, School of Medicine, Jinan University, Guangzhou, 510632, China. Major MEDLINE topics: Brain-Derived Neurotrophic Factor, Ketamine, Antidepressive Agents, Microglia. Cited 16 times so far (Crossref); 72 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Arketamine, the ( R )-enantiomer of ( R,S )-ketamine, shows even greater rapid and sustained antidepressant-like effects in rodent models compared to esketamine, yet the underlying mechanisms remain unclear. In this study, we used the chronic social defeat stress (CSDS) model to investigate how arketamine exerts its antidepressant-like effects. We found that activating cAMP response element–binding protein (CREB) at S133 and methyl-CpG–binding protein 2 (MeCP2) at S421 drives the transcription of brain-derived neurotrophic factor (BDNF), contributing to arketamine’s antidepressant-like effects. Furthermore, microglia-derived BDNF enhances excitatory synaptic transmission in the infralimbic (IL) region of the medial prefrontal cortex (mPFC), mediating the antidepressant-like effects of arketamine in CSDS-susceptible mice. Last, microglia-derived BDNF can activate mPFC (IL) neurons projecting to the nucleus accumbens (NAc) shell, contributing to arketamine’s antidepressant-like effects. These findings highlight the essential role of microglial BDNF in modulating NAc-projecting mPFC neurons, which contribute to the antidepressant-like effects of arketamine.

Subjects

MeSH terms (MEDLINE)

Brain-Derived Neurotrophic FactorKetamineAntidepressive AgentsMicrogliaNucleus AccumbensPrefrontal CortexAnimalsMiceMaleDisease Models, AnimalCyclic AMP Response Element-Binding ProteinDepressionMice, Inbred C57BLSynaptic Transmission

Substances

Brain-Derived Neurotrophic FactorKetamineAntidepressive AgentsCyclic AMP Response Element-Binding ProteinBdnf protein, mouse

Authors and institutions

  • Department of Physiology, School of Medicine, Jinan University, Guangzhou, 510632, China.
  • Institute of Brain Science and Brain-inspired Research, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Department of Neurology, Xiangya Hospital, National Clinical Research Center for Geriatric Disorders, and Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Guangzhou Key Laboratory of Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632, China.
  • Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.

ORCID profiles: Lujuan He, Shilin Luo, Chun Yang, Wei Yao, Kenji Hashimoto, Ji-Chun Zhang

Cite

APA

He, L., Wang, X., Luo, S., Jiang, N., Yan, Y., Xie, M., Chen, Y., Yang, C., Yao, W., Hashimoto, K., & Zhang, J. C. (2025). Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways. Science Advances. https://doi.org/10.1126/sciadv.adv5986

Vancouver

He L, Wang X, Luo S, Jiang N, Yan Y, Xie M, et al. Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways. Science Advances. 2025. doi:10.1126/sciadv.adv5986

BibTeX
@article{He2025,
  author = {He, Lujuan and Wang, Xuenan and Luo, Shilin and Jiang, Nan and Yan, Yu and Xie, Min and Chen, Yueyue and Yang, Chun and Yao, Wei and Hashimoto, Kenji and Zhang, Ji-Chun},
  title = {Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adv5986}
}
Start for free →